Fulgent Genetics (FLGT) Receivables - Net (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Receivables - Net for 11 consecutive years, with $84.8 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 22.81% to $84.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.8 million through Dec 2025, up 22.81% year-over-year, with the annual reading at $84.8 million for FY2025, 22.81% up from the prior year.
- Receivables - Net hit $84.8 million in Q4 2025 for Fulgent Genetics, up from $71.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $216.5 million in Q1 2021 to a low of $11000.0 in Q1 2024.
- Historically, Receivables - Net has averaged $82.0 million across 5 years, with a median of $71.3 million in 2025.
- Biggest five-year swings in Receivables - Net: tumbled 99.99% in 2023 and later surged 649700.0% in 2025.
- Year by year, Receivables - Net stood at $138.9 million in 2021, then tumbled by 99.93% to $93000.0 in 2022, then soared by 54880.65% to $51.1 million in 2023, then soared by 34.99% to $69.0 million in 2024, then rose by 22.81% to $84.8 million in 2025.
- Business Quant data shows Receivables - Net for FLGT at $84.8 million in Q4 2025, $71.2 million in Q3 2025, and $77.2 million in Q2 2025.